Silicon Laboratories Inc. — Form 10-Q Summary
Period clarification: The filing covers the quarter ended July 4, 2015 (fiscal Q2 2015), with comparisons to the quarter ended June 28, 2014. This differs from the request metadata’s “2014 Q2.” Financial amounts below are in U.S. dollars; millions unless stated otherwise.
Business context and reporting period
Silicon Labs designs analog-intensive, mixed-signal integrated circuits for IoT, broadcast, infrastructure and access markets. It operates as a fabless semiconductor company, relying on third parties for wafer fabrication, assembly and testing. Bluegiga, acquired in January 2015, expanded the company’s Bluetooth and Wi-Fi module and software offerings.
Key financial results
| Metric | Q2 FY2015 | Q2 FY2014 | First half FY2015 | First half FY2014 |
|---|---|---|---|---|
| Revenue | $164.9 | $154.9 | $328.6 | $300.6 |
| Gross margin | $97.4; 59.1% | $98.7; 63.7% | $193.8; 59.0% | $185.8; 61.8% |
| Operating income | $9.0 | $20.8 | $16.2 | $30.8 |
| Net income | $7.6 | $14.3 | $14.0 | $22.4 |
| Diluted EPS | $0.17 | $0.32 | $0.32 | $0.51 |
| Operating cash flow | Not separately stated for the quarter | $37.2 | $63.4 |
Q2 revenue increased 6.4% year over year, while operating income and net income declined. IoT revenue rose 34.8% to $68.9 million; Broadcast revenue fell 21.9% to $39.4 million. For the first half, revenue increased 9.3%, with IoT up 30.8% and Broadcast down 15.4%. Management attributed IoT growth to market-share gains, market growth and Bluegiga contributions; weaker consumer IC demand and market-share declines weighed on Broadcast.
Q2 gross margin fell 4.6 percentage points year over year. The prior-year quarter included $5.0 million from patent sales with no associated cost of revenue; Q2 FY2015 included $1.3 million of Bluegiga inventory fair-value write-up charges. Operating expenses increased: R&D rose 13.4% and SG&A rose 13.7% in Q2, principally reflecting personnel costs, amortization and acquisition-related contingent consideration adjustments.
Balance sheet, cash flow and liquidity
- At July 4, 2015, cash and cash equivalents were $125.1 million and short-term investments were $147.6 million. Management cited $272.6 million of cash, cash equivalents and short-term investments; approximately $213.6 million was held by U.S. entities.
- Total assets were $1.036 billion, total liabilities $249.7 million and stockholders’ equity $786.2 million. Reported debt was $84.6 million, including $10.0 million current and $74.6 million long term.
- First-half operating cash flow was $37.2 million, down from $63.4 million. Net income was $14.0 million; working-capital changes produced a net cash outflow of $23.7 million. Inventory increased to $60.7 million from $52.6 million; days of inventory rose to 81 from 73.
- First-half investing cash outflow was $37.6 million, including $76.9 million in net acquisition payments, partly offset by investment maturities and sales. Financing cash outflow was $16.2 million, including $10.4 million of share repurchases, $4.5 million of acquisition-related contingent consideration and debt payments.
- The company was in compliance with credit-facility covenants at quarter end. On July 24, 2015, after the reporting date, it amended its credit agreement to a $300 million five-year revolving facility and borrowed $82.5 million to repay the remaining term loan balance.
Outlook, commentary and material risks
- For fiscal Q3 2015, management forecast revenue of $151–$156 million and diluted EPS of $0.04–$0.10. It expected R&D expense to remain relatively stable in absolute dollars and SG&A expense to decrease from Q2 levels.
- Management expected existing cash, investments and credit availability to meet capital requirements for at least 12 months. Fiscal 2015 capital expenditures were estimated at $14–$16 million.
- All revenue was denominated in U.S. dollars; 84% of first-half revenue came from outside the United States. Distributors represented 65% of revenue, and two distributors each exceeded 10% of revenue. No individual customer exceeded 10%.
- Key exposures include semiconductor cyclicality, customer and product concentration, pricing and margin pressure, long product qualification and sales cycles, reliance on third-party manufacturing capacity, forecast-related inventory risk, international operations, and acquisition integration and valuation risks. Inventory was building partly for new product ramps and a foundry transition.
- The company held $8.0 million par value of failed-auction auction-rate securities, carried at $7.2 million, with contractual maturities from 2033 to 2046. Management said it did not expect to need access to the funds before maturity and recorded no other-than-temporary impairment.
- Cresta Technology patent litigation involving television tuner products remained unresolved. An ITC administrative law judge found no violation by Silicon Labs; the ITC’s final determination was scheduled for August 19, 2015. The company had not accrued a material liability and said the financial impact could not be predicted.
- Effective tax rates were 11.2% for Q2 and 10.5% for the first half, versus 29.4% and 24.9% in the comparable periods, primarily reflecting increased foreign tax benefits associated with completion of intercompany licensing payments.
Important facts for investors to verify
- Confirm the intended period: the supplied filing is fiscal Q2 2015, not Q2 2014.
- Track whether IoT growth can offset continued Broadcast weakness, and whether gross margin recovers after the patent-sale comparison and Bluegiga inventory charges.
- Review Q3 performance against the revenue and diluted EPS outlook, including expense trends and acquisition-related costs.
- Monitor inventory levels, the manufacturing transition, and Bluegiga integration and earn-out assumptions.
- Check the outcome of the Cresta ITC proceeding and any subsequent material litigation developments.
- Assess liquidity and debt after the July 24 refinancing, including facility terms, covenant compliance and the availability of cash held overseas.